Junevity

San Francisco, United States

Junevity develops medicines targeting transcription factors to reverse diseases of aging.

$10.0M raised

Dec 2025

Seed

Top Investors

Goldcrest CapitalGodfrey Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Junevity raised?

Junevity has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in December 2025.

Who are Junevity's investors?

Junevity's investors include Goldcrest Capital, Godfrey Capital.

Where is Junevity headquartered?

Junevity is headquartered in San Francisco, United States.

What does Junevity do?

Junevity develops medicines targeting transcription factors to reverse diseases of aging.

What stage is Junevity at?

Junevity is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 3, 2025.

MLA

"Junevity — Funding & Investors." VCBacked, December 3, 2025, https://www.vcbacked.co/company/junevity. Accessed June 17, 2026.

APA

VCBacked. (2025). Junevity — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/junevity

Wikipedia (cite web)

{{cite web |title=Junevity — Funding & Investors |url=https://www.vcbacked.co/company/junevity |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 3, 2025.